“Grade 4 Pneumonitis in a Patient Treated with a Combination of Gemcitabine and Docetaxel for Recurrent Leiomyosarcoma of the Uterus” describes a case of inflamed lung tissue, followed by other complications, in a patient being treated for uterine cancer using two particular chemotherapy drugs. The case study includes important suggestions for other providers using those drugs in their treatment plans:
“Physicians should not only be aware of gemcitabine and docetaxel’s potential to cause life-threatening pulmonary injuries but also recognize the variability in clinical presentations and treatment responses, the radiographic findings of these lung toxicities, and the need for early corticosteroid therapy in these cases.”
UW Ob-Gyn gynecologic oncologists Stephen Rose, MD and Ryan Spencer, MD co-authored the article with Wang. Read the whole case study here.
Amazing work, Dr. Wang!